Stock Events

Stock Events

Ainos 

$0.099700
20
+$0.03+42.43% Tuesday 17:22
+$0.00+0%Tuesday 20:00After hours

Statistics

Day High
0.0997
Day Low
0.0997
52W High
0.1035
52W Low
0.0701
Volume
200
Avg. Volume
-
Mkt Cap
734,244.84
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

13MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-1.36
-0.91
-0.45
0
Expected EPS
N/A
Actual EPS
-0.57

Financials

-11,912.1%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
124,000Revenue
-14.77MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AIMDW. It's not an investment recommendation.
Coca-Cola
2
KO
Bitcoin
2
BTC.CRYPTO
Ethereum
2
ETH.CRYPTO
Palantir Technologies
2
PLTR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a global pharmaceutical company that competes with Ainos in the development and marketing of medications and therapies, including those in Ainos' focus areas.
Merck
MRK
Mkt Cap335.14B
Merck is a leading pharmaceutical company that develops medicines and vaccines, directly competing with Ainos in various therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its pharmaceutical segment, competes with Ainos in researching and developing healthcare solutions, including drugs and treatments.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie operates in the pharmaceuticals sector, focusing on immunology, oncology, and virology, areas that may overlap with Ainos' interests.
AMGEN
AMGN
Mkt Cap224.63B
Amgen is a biotechnology company that competes with Ainos in the development of innovative therapeutics in various disease areas.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines that compete with Ainos' product offerings.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences is a biopharmaceutical company that competes with Ainos in the development and commercialization of therapeutics in areas like infectious disease.
Novartis
NVS
Mkt Cap286.78B
Novartis is a global healthcare company that competes with Ainos in researching and developing innovative medicines in various therapeutic areas.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that competes with Ainos in the pharmaceutical and diagnostics sectors, focusing on innovative treatments.
Sanofi
SNY
Mkt Cap104.76B
Sanofi is a global biopharmaceutical company that competes with Ainos in the development and marketing of healthcare solutions across multiple therapeutic areas.

About

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
Show more...
CEO
Chun-Hsien Tsai
Employees
41
Country
United States
ISIN
US00902F1131

Listings

STU
DE
FZX0.STU
XNAS
US
AIMDW
XNAS
US
AIMD
F
DE
FZX0.F

0 Comments

Share your thoughts

FAQ

What is Ainos stock price today?▼
The current price of AIMDW is $0.10 USD — it has increased by +42.43% in the past 24 hours. Watch Ainos stock price performance more closely on the chart.
What is Ainos stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Ainos stocks are traded under the ticker AIMDW.
What is Ainos market cap?▼
Today Ainos has the market capitalization of 734,244.84
What is Ainos revenue for the last year?▼
Ainos revenue for the last year amounts to 124,000 USD.
What is Ainos net income for the last year?▼
AIMDW net income for the last year is -14.77M USD.
How many employees does Ainos have?▼
As of August 19, 2026, the company has 41 employees.
In which sector is Ainos located?▼
Ainos operates in the Health & Wellness sector.
When did Ainos complete a stock split?▼
The last stock split for Ainos was on June 30, 2025 with a ratio of 1:5.
Where is Ainos headquartered?▼
Ainos is headquartered in HOUSTON, United States.